HK1144192A1 - Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222] - Google Patents

Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222]

Info

Publication number
HK1144192A1
HK1144192A1 HK10110355.6A HK10110355A HK1144192A1 HK 1144192 A1 HK1144192 A1 HK 1144192A1 HK 10110355 A HK10110355 A HK 10110355A HK 1144192 A1 HK1144192 A1 HK 1144192A1
Authority
HK
Hong Kong
Prior art keywords
azabiciyclo
fluorophenyl
oct
ester
crystalline salt
Prior art date
Application number
HK10110355.6A
Other languages
English (en)
Chinese (zh)
Inventor
Ruiz Juan Lorenzo Catena
Rodriguez Jos Hidalgo
Comas Maria Del Carmen Serra
Masip Isabel Masip
Original Assignee
Salvat Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvat Lab Sa filed Critical Salvat Lab Sa
Publication of HK1144192A1 publication Critical patent/HK1144192A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK10110355.6A 2007-11-28 2010-11-04 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222] HK1144192A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07384038A EP2065385A1 (en) 2007-11-28 2007-11-28 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
PCT/EP2008/010012 WO2009068253A2 (en) 2007-11-28 2008-11-26 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester

Publications (1)

Publication Number Publication Date
HK1144192A1 true HK1144192A1 (en) 2011-02-02

Family

ID=39401152

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10110355.6A HK1144192A1 (en) 2007-11-28 2010-11-04 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222]

Country Status (19)

Country Link
US (2) US8492402B2 (xx)
EP (2) EP2065385A1 (xx)
JP (1) JP5336509B2 (xx)
KR (1) KR101557832B1 (xx)
CN (1) CN101925600B (xx)
AU (1) AU2008329181B2 (xx)
BR (1) BRPI0819607A2 (xx)
CA (1) CA2706565C (xx)
DK (1) DK2220082T3 (xx)
EA (1) EA017483B1 (xx)
ES (1) ES2498819T3 (xx)
HK (1) HK1144192A1 (xx)
IL (1) IL206032A (xx)
MX (1) MX2010005850A (xx)
NZ (1) NZ585833A (xx)
PL (1) PL2220082T3 (xx)
UA (1) UA102083C2 (xx)
WO (1) WO2009068253A2 (xx)
ZA (1) ZA201003718B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051841A1 (en) 2000-12-22 2002-07-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
KR102108226B1 (ko) 2010-02-12 2020-05-08 화이자 인코포레이티드 8-플루오로-2-{4-[(메틸아미노)메틸]페닐}-1,3,4,5-테트라하이드로-6h-아제피노[5,4,3-cd]인돌-6-온의 염 및 다형체
KR101978364B1 (ko) 2017-06-15 2019-05-14 크리스탈지노믹스(주) 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
DK1300407T4 (da) 2000-06-27 2011-09-05 S A L V A T Lab Sa Carbamater afledt af arylalkylaminer
WO2002051841A1 (en) * 2000-12-22 2002-07-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
WO2003053966A2 (en) 2001-12-20 2003-07-03 Laboratorios S.A.L.V.A.T., S.A. 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.

Also Published As

Publication number Publication date
EA017483B1 (ru) 2012-12-28
WO2009068253A2 (en) 2009-06-04
AU2008329181A1 (en) 2009-06-04
IL206032A (en) 2014-07-31
MX2010005850A (es) 2010-09-03
US20140051721A1 (en) 2014-02-20
EA201070651A1 (ru) 2010-12-30
ZA201003718B (en) 2011-08-31
EP2065385A1 (en) 2009-06-03
DK2220082T3 (da) 2014-10-06
PL2220082T3 (pl) 2014-12-31
NZ585833A (en) 2011-05-27
UA102083C2 (xx) 2013-06-10
JP2011504890A (ja) 2011-02-17
US20110207769A1 (en) 2011-08-25
EP2220082A2 (en) 2010-08-25
JP5336509B2 (ja) 2013-11-06
ES2498819T3 (es) 2014-09-25
US8871787B2 (en) 2014-10-28
KR20100103532A (ko) 2010-09-27
KR101557832B1 (ko) 2015-10-06
IL206032A0 (en) 2010-11-30
WO2009068253A3 (en) 2009-08-13
CN101925600B (zh) 2013-01-09
BRPI0819607A2 (pt) 2015-10-13
CA2706565A1 (en) 2009-06-04
CA2706565C (en) 2015-04-28
US8492402B2 (en) 2013-07-23
AU2008329181B2 (en) 2012-03-29
EP2220082B1 (en) 2014-06-25
CN101925600A (zh) 2010-12-22

Similar Documents

Publication Publication Date Title
HK1209628A1 (en) Methods, compounds, compositions and vehicles for delivering 3-amino- 1-propanesulfonic acid 3--1-
PL2350075T3 (pl) Podstawione związki imidazo[1,2b]pirydazynowe jako inhibitory kinaz Trk
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2009083940A3 (en) Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
AU2008329909A8 (en) Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3- carboxylic acid amides
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
ZA200905832B (en) Crystalline forms of an 8-azabicyclo [3.2.1] octane compound
AU2008287784A1 (en) Phenylacetic acid compound
HRP20181437T1 (hr) Postupak proizvodnje (3s,3s') 4,4' disulfanedilbis (3-aminobutan-1-sulfonske kiseline)
WO2010008735A3 (en) Solid states of o-desmethylvenlaf axine salts
ZA201107412B (en) Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
PL2213669T3 (pl) Krystaliczna pochodna kwasu imidazolo-5-karboksylowego
EP2212325A4 (en) 2-ARYLMETHYLAZETIDINCARBAPENEM-3-CARBOXYLENE DERTERIVATE OR SALT, METHOD FOR THE PRODUCTION THEREOF AND THEREOF COMPRISING PHARMACEUTICAL COMPOSITION
WO2009037538A3 (en) Process for the preparation of lamivudine form i
HK1144192A1 (en) Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester (r)-3--345- 1-[222]
WO2009122429A3 (en) Crystalline oxybutynin and process for preparing the same
IL213171A (en) Composition for producing trans-2,2 dimethyl 3-formylcyclopropanecarboxylic acid ester
WO2011058521A3 (en) Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
EP2077994A4 (en) CRYSTALLINE WATER-FREE S - (-) - AMLODIPINADIPINIC ACID SALT AND METHOD FOR THE PRODUCTION THEREOF
EP2468879A4 (en) A-87774 COMPOUND OR SALT THEREOF, METHOD FOR THE PRODUCTION OF THE COMPOUND OR THE SALT, AND AGRICULTURAL CHEMICALS WITH THE COMPOUND OR THE SALT THEREOF AS ACTIVE SUBSTANCE
EP2053032A4 (en) METHOD FOR PRODUCING AN OPTICALLY ACTIVE HYDROXYCARBOXYLENE DERIVATIVE OR SALT THEREOF
AU2007905798A0 (en) alpha-Cyclopropyl-alpha-Amino Carboxylic Acid Compounds and Methods for their Preparation
AU2007904276A0 (en) Acid sulphate soil treatment

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171126